Status:

COMPLETED

Medications Development for Drug Abuse Disorders

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Opioid Related Disorders

Opioid Dependence

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

This is a study of tramadol as an agent for short-term opioid withdrawal treatment. A randomized, double blind clinical trial comparing the efficacy and safety of tramadol to clonidine and buprenorphi...

Eligibility Criteria

Inclusion

  • Inclusion/Exclusion Criteria:
  • Participants in this study will be males and females between the ages of 18 and 60 years.
  • Applicants must be opioid dependent based upon the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (SCID); in addition, they must have an opioid positive urine during the screening process (or have evidence of opioid withdrawal).
  • They must be healthy, with no significant medical illnesses (e.g., insulin dependent diabetes), and without significant psychiatric illness (e.g., schizophrenia) besides their drug dependence.
  • Females will have a pregnancy test prior to study enrollment, and if found to be pregnant will be excluded and referred to a substance abuse program for pregnant women (the Center for Addiction and Pregnancy) on the campus.
  • Volunteers will also be excluded if they have pre-admission hypotension (due to the use of clonidine in the study).
  • Applicants with a history of seizures (including substance-related seizures, such as alcohol withdrawal related) will be excluded.
  • Alcohol and/or sedative dependence will be specific exclusionary criteria (given the small risk of seizures associated with tramadol use).
  • Allergies to any of the study medications will be grounds for exclusion.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2015

    Estimated Enrollment :

    106 Patients enrolled

    Trial Details

    Trial ID

    NCT01188421

    Start Date

    October 1 2010

    End Date

    June 1 2015

    Last Update

    July 6 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Johns Hopkins University (BPRU) Bayview Campus

    Baltimore, Maryland, United States, 21224

    Medications Development for Drug Abuse Disorders | DecenTrialz